Table 2

Clinicopathologic characteristics, COX-2 expression and TIL in comparison to recurrence of non-muscle invasive bladder carcinoma
Recurrent disease
N=127 Yes (n=78) No (n=49) P-value
Gender Cases (%) Cases (%)
 Male 58 (74) 36 (73) 0.8834
 Female 20 (26) 13 (27)
Age (years, median, range) 71 (41 – 87) 67 (54 – 78)
Tumor size: Cases (%) Cases (%)
 > 3 cm 40 (51) 19 (39) 0.1104
 ≤ 3 cm 38 (49) 30 (61)
Pathology: Cases (%) Cases (%)
 PUNLMP 26 (38) 28 (61) 0.0258
 LGPUC 43 (62) 18 (39)
Disease stage Cases (%) Cases (%)
Ta 26 (37) 28 (61) 0,0182
T1 46 (63) 18 (39)
Median follow-up (months) 13 75
COX-2 score Cases (%) Cases (%)
 0 27 (45) 2 (5) 0.0001
 1 7 (12) 9 (23) 0.2196
 2 26 (43) 28 (72) 0.0101
TILs* Cases (%) Cases (%)
 No 32 (53) 12 (26) 0.009
 Yes 29 (47) 35 (74)

Note: PUNLMP indicates papillary urothelial neoplasm of low malignant potential; LGPUC, low-grade papillary urothelial carcinoma; * tumor-infiltrating lymphocytes.

Tadin et al.

Tadin et al. Diagnostic Pathology 2012 7:152   doi:10.1186/1746-1596-7-152

Open Data